Læknablaðið - 15.11.2001, Blaðsíða 18

FRÆÐIGREINAR / IgA MÓTEFNASKORTUR
significance of IgG subclasses and mannan-binding lectin
(MBL) for susceptibility to infection in apparently healthy
adults with IgA deficiency. Clin Exp Immunol 1999; 116: 505-8.
3. Brasher GW, Bourland PD. The role of IgA in the patho-
genesis of atopy. Ann Allergy 1975; 34:137-40.
4. Burrows PD, Cooper MD. IgA deficiency. Adv Immunol 1997;
65: 245-76.
5. Cataldo F, Marino V, Bottaro G, Greco P, Ventura A. Celiac
disease and selective immunoglobulin A deficiency. J Pediatr
1997; 131:306-8.
6. Castrignano SB, Carlsson B, Carneiro-Sampaio MS, Soder-
strom T, Hanson LA. IgA and IgG subclass deficiency in a
poor population in a developing country. Scand J Immunol
1993; 37: 509-14.
7. Hahn-Zoric M, Carlsson B, Bjorkander J, Mellander L,
Friman V, Padyukov L, et al. Variable increases of IgG and
IgM antibodies in milk of IgA deficient women. Pediatr
Allergy Immunol 1997; 8:127-33.
8. Benson EB, Strober W. Regulation of IgA secretion by T cell
clones derived from the human gastrointestinal tract. J
Immunol 1988; 140:1874-82.
9. Johnson ML, Keeton LG, Zhu ZB, Volanakis JE, Cooper MD,
Schroeder HW, Jr. Age-related changes in serum immuno-
globulins in patients with familial IgA deficiency and common
variable immunodeficiency (CVID). Clin Exp Immunol 1997;
108: 477-83.
10. Koskinen S. Long-term follow-up of health in blood donors
with primary selective IgA deficiency. J Clin Immunol 1996;
16:165-70.
11. Korponay-Szabo IR, Kovacs JB, Czinner A, Goracz G, Vamos
A, Szabo T, et al. High prevalence of silent celiac disease in
preschool children screened with IgA/IgG antiendomysium
antibodies. J Pediatr Gastroenterol Nutr 1999; 28: 26-30.
12. Rankin EC, Isenberg DA. IgA deficiency and SLE: prevalence
in a clinic population and a review of the literature. Lupus
1997; 6: 390-4.
13. Steuer A, McCrea DJ, Colaco CB. Primary Sjogren's synd-
rome, ulcerative colitis and selective IgA deficiency. Postgrad
Med J 1996; 72: 499-500.
14. Ehrhardt RO, Strober W, Harriman GR. Effect of trans-
forming growth factor (TGF)-beta 1 on IgA isotype expres-
sion. TGF-beta 1 induces a small increase in sIgA+ B cells
regardless of the method of B cell activation. J Immunol 1992;
148: 3830-6.
15. Stuber E, Strober W, Neurath M. Blocking the CD40L-CD40
interaction in vivo specifically prevents the priming of T
helper 1 cells through the inhibition of interleukin 12
secretion. J Exp Med 1996; 183: 693-8.
16. Elson CO, Heck JA, Strober W. T-cell regulation of murine
IgA synthesis. J Exp Med 1979; 149: 632-43.
17. Harriman GR, Bogue M, Rogers P, Finegold M, Pacheco S,
Bradley A, et al. Targeted deletion of the IgA constant region
in mice leads to IgA deficiency with alterations in expression
of other Ig isotypes. J Immunol 1999; 162:2521-9.
18. Hiroi T, Yanagita M, Iijima H, Iwatani K, Yoshida T, Takatsu
K, et al. Deficiency of IL-5 receptor alpha-chain selectively
influences the development of the common mucosal immune
system independent IgA-producing B-1 cell in mucosa-
associated tissues. J Immunol 1999; 162: 821-8.
19. Marconi M, Plebani A, Avanzini MA, Maccario R, Pistorio A,
Duse M, et al. IL-10 and IL-4 co-operate to normalize in vitro
IgA production in IgA-deficient (IgAD) patients. Clin Exp
Immunol 1998; 112: 528-32.
20. Wang Z, Yunis D, Irigoyen M, Kitchens B, Bottaro A, Alt FW,
et al. Discordance between IgA switching at the DNA level
and IgA expression at the mRNA level in IgA-deficient
patients. Clin Immunol 1999; 91: 263-70.
21. Kerr MA. The structure and function of human IgA. Biochem
J 1990; 271: 285-96.
22. Conley ME, Delacroix DL. Intravascular and mucosal
immunoglobulin A: two separate but related systems of
immune defense? Ann Intern Med 1987; 106: 892-9.
23. Kilian M, Reinholdt J, Lomholt H, Poulsen K, Frandsen EV.
Biological significance of IgAl proteases in bacterial coloni-
zation and pathogenesis: critical evaluation of experimental
evidence. Apmis 1996; 104: 321-38.
24. Calvo M, Pol A, Lu A, Ortega D, Pons M, Blasi J, et al. Cellu-
brevin is present in the basolateral endocytic compartment of
hepatocytes and follows the transcytotic pathway after IgA
internalization. J Biol Chem 2000; 275: 7910-7.
25. Delacroix DL, Elkom KB, Geubel AP, Hodgson HF, Dive C,
Vaerman JP. Changes in size, subclass, and metabolic proper-
ties of serum immunoglobulin A in liver diseases and in other
diseases with high serum immunoglobulin A. J Clin Invest
1983;71:358-67.
26. Brandtzaeg P. Molecular and cellular aspects of the secretory
immunoglobulin system. Apmis 1995; 103:1-19.
27. Brandtzaeg P, Farstad IN, Johansen FE, Morton HC,
Norderhaug IN. Yamanaka T. The B-cell system of human
mucosae and exocrine glands. Immunol Rev 1999; 171: 45-87.
28. Renegar KB, Jackson GD, Mestecky J. In vitro comparison of
the biologic activities of monoclonal monomeric IgA, poly-
meric IgA, and secretory IgA. J Immunol 1998; 160:1219-23.
29. Lycke N, Erlandsson L, Ekman L, Schon K, Leanderson T.
Lack of J chain inhibits the transport of gut IgA and abrogates
the development of intestinal antitoxic protection. J Immunol
1999; 163: 913-9.
30. Shimada S, Kawaguchi-Miyashita M, Kushiro A, Sato T,
Nanno M, Sako T, et al. Generation of polymeric immuno-
globulin receptor-deficient mouse with marked reduction of
secretory IgA. J Immunol 1999; 163: 5367-73.
31. Persson CG, Erjefalt JS, Greiff L, Erjefalt I, Korsgren M,
Linden M, et al. Contribution of plasma-derived molecules to
mucosal immune defence, disease and repair in the airways.
Scand J Immunol 1998; 47: 302-13.
32. Porter P, Linggood MA. Novel mucosal anti-microbial func-
tions interfering with the plasmid-mediated virulence determi-
nants of adherence and drug resistance. Ann N Y Acad Sci
1983; 409: 564-79.
33. Koistinen J. Selective IgA deficiency in blood donors. Vox
Sang 1975; 29:192-202.
34. Sampaio MM, Carbonare SB, Rozentraub RB, Mamede MN,
Ribeiro MA, Porto MH, et al. [Prevalence of selective IgA
deficiency in blood donors and pregnant women clinically
healthy [letter]]. Rev Paul Med 1987; 105: 239-40.
35. Wells JV, McNalIy MP, King MA. Selective IgA deficiency in
Australian blood donors. Aust N Z J Med 1980; 10: 410-3.
36. Clark JA, Callicoat PA, Brenner NA, Bradley CA, Smith DM,
Jr. Selective IgA deficiency in blood donors. Am J Clin Pathol
1983; 80: 210-3.
37. Kanoh T, Mizumoto T, Yasuda N, Koya M, Ohno Y, Uchino H,
et al. Selective IgA deficiency in Japanese blood donors:
frequency and statistical analysis. Vox Sang 1986; 50: 81-6.
38. Gudmundsson S, Jensson O. Frequency of IgA deficiency in
blood donors and Rh negative women in Iceland. Acta Pathol
Microbiol Scand [C] 1977; 85: 87-9.
39. Ludviksson BR, Eiriksson TH, Ardal B, Sigfusson A,
Valdimarsson H. Correlation between serum immunoglobulin
A concentrations and allergic manifestations in infants. J
Pediatr 1992; 121:23-7.
40. Strober W, Sneller MC. IgA deficiency. Ann Allergy 1991; 66:
363-75.
41. Ramesh N, Seki M, Notarangelo LD, Geha RS. The hyper-IgM
(HIM) syndrome. Springer Semin Immunopathol 1998; 19:
383-99.
42. Bridoux F, Badou A, Saoudi A, Bernard I, Druet E, Pasquier
R, et al. Transforming growth factor beta (TGF-beta)-depen-
dent inhibition of T helper cell 2 (Th2)-induced autoimmunity
by self-major histocompatibility complex (MHC) class II-
specific, regulatory CD4(+) T cell lines. J Exp Med 1997; 185:
1769-75.
43. Conley ME, Cooper MD. Genetic basis of abnormal B cell
development. Curr Opin Immunol 1998; 10: 399-406.
44. Del Giudice G, Crow MK. Role of transforming growth factor
beta (TGF beta) in systemic autoimmunity. Lupus 1993; 2:
213-20.
45. Horwitz DA, Gray JD, Ohtsuka K, Hirokawa M, Takahashi T.
The immunoregulatory effects of NK cells: the role of TGF-
beta and implications for autoimmunity. Immunol Today 1997;
18: 538-42.
46. Inobe J. Slavin AJ, Komagata Y, Chen Y, Liu L, Weiner HL.
IL-4 is a differentiation factor for transforming growth factor-
beta secreting Th3 cells and oral administration of IL-4
enhances oral tolerance in experimental allergic encephalo-
myelitis. Eur J Immunol 1998; 28: 2780-90.
47. Lio D, D'Anna C, Leone F, Curro MF, Candore G, Caruso C.
Hypothesis: interleukin-5 production impairment can be a key
point in the pathogenesis of the MHC-linked selective IgA
deficiency. Autoimmunity 1998; 27:185-8.
48. Muller F, Aukrust P, Nilssen DE, Froland SS. Reduced serum
level of transforming growth factor-beta in patients with IgA
deficiency. Clin Immunol Immunopathol 1995; 76: 203-8.
49. Piccirillo CA, Chang Y, Prud'homme GJ. TGF-betal somatic
gene therapy prevents autoimmune disease in nonobese
diabetic mice. J Immunol 1998; 161: 3950-6.
50. van Ginkel FW, Wahl SM, Kearney JF, Kweon MN, Fujihashi
K, Burrows PD, et al. Partial IgA-deficiency with increased
Th2-type cytokines in TGF-beta 1 knockout mice. J Immunol
1999; 16:1951-7.
51. Zan H, Cerutti A, Dramitinos P, Schaffer A, Casali P. CD40
878 Læknablaðið 2001/87